Skip to main content
SpringerLink
Log in

Comorbidity and polypharmacy in patients with breast cancer

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Cancer sufferers are aged ≥ 65 years, but research has focused infrequently on elderly patients with the majority of cancer. We aimed not only to determine the frequency of comorbidity and polypharmacy, but also to present the discrepiancies in elderly versus non-elderly patients with breast cancer.

Methods

A total of 352 female patients aged over 18 years, 252 non-elderly and 100 elderly, followed-up in the oncology department of a tertiary hospital between January 2016 and September 2019 were retrospectively screened. Demographic data, comorbidity and medications of the patients were recorded hospital data processing system. Polypharmacy was defined as the use of ≥ 5 different medications.

Results

The most common four chronic diseases in both non-elderly and elderly groups were muscle-joint-bone disease, gastrointestinal diseases, diabetes mellitus and hypertension. The most common four prescribed drugs were NSAID, adjuvant endocrine therapy, PPI, and vitamin D or/and calcium in non-elderly group while those were ACEI-ARB, PPI, NSAID, and diuretics in elderly one. The frequency of polypharmacy was 50% (n = 126) in the non-elderly patients and 74% (n = 74) in the elderly ones. These were considered statistically significant (p < 0.001). The mean number of prescription medication categories reported was 5.02 (SD = 2.90; range 0–14) in non-elderly group whereas those was 6.83 (SD = 3.18; range 0–15) in elderly one (p < 0.001). The mean of ages were 47.9 years (without polypharmacy) and 51.3 years (with polypharmacy) in non-elderly patients while those are, respectively, 70.9 years and 74.7 years in elderly ones. These were considered statistically significant (respectively; p = 0.006, p = 0.009).

Conclusions

We first gained to raise awareness in the literature of comorbidity and polypharmacy in patients with breast cancer and to compare between the elderly and non-elderly participants. For the effectiveness of cancer treatment, importance in geriatric population, attention to drug–drug interaction, such studies should be considered during clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pilato B, Martinucci M, Danza K, Pinto R, Petriella D, Lacalamita R, et al. Mutations and polymorphic BRCA variants transmission in breast cancer familial members. Breast Cancer Res Treat. 2011;125(3):651–7.

    Article  CAS  Google Scholar 

  2. Yang X, Lippman ME. BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat. 1999;4:1–10.

    Article  Google Scholar 

  3. Ritchie CS, Kvale E, Fisch MJ. Multimorbidity: an issue of growing importance for oncologists. J Oncol Pract. 2011;7:371–4.

    Article  Google Scholar 

  4. Neugut AI, Zhong X, Wright JD, Accordino M, Yang J, Hershman DL. Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncol. 2016;2(10):1326–32.

    Article  Google Scholar 

  5. Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, et al. Prevalence and factors associated with polypharmacy in older people with cancer. Support Care Cancer. 2014;22(7):1727–34.

    Article  Google Scholar 

  6. Ballentine HN. Polypharmacy in the elderly. Crit Care Nurs Q. 2008;31:4.

    Article  Google Scholar 

  7. Önal Ö, Durukan E. Frequency of polypharmacy and risk factors in the elderly in Burdur. Turkish J Geriatr. 2018;21(4):550–6.

    Article  Google Scholar 

  8. Azuero A, Benz R, McNees P, Meneses K. Co-morbidity and predictors of health status in older rural breast cancer survivors. Springerplus. 2014;3:102.

    Article  Google Scholar 

  9. Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol. 2011;12(13):1249–57.

    Article  Google Scholar 

  10. Bellury L, Pett MA, Ellington L, Beck SL, Clark JC, Stein KD. The effect of aging and cancer on the symptom experience and physical function of elderly breast cancer survivors. Cancer. 2012;118(24):6171–8.

    Article  Google Scholar 

  11. Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253–61.

    Article  Google Scholar 

  12. Williams GR, Deal AM, Lund JL, Chang Y, Muss HB, Pergolotti M, et al. Patient-reported comorbidity and survival in older adults with cancer. Oncologist. 2018;23(4):433–9.

    Article  Google Scholar 

  13. Arinc S, Ece F, Ertugrul M, Erdal N, Oruc O, Hatabay N, et al. Analysis of young and elderly advanced stage nonsmall-cell lung carcinoma cases. South Med J. 2009;102(10):1019–22.

    Article  Google Scholar 

  14. Jorgensen TL, Hallas J, Friis S, Herrstedt J. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer. 2012;106(7):1353–60.

    Article  CAS  Google Scholar 

  15. Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, et al. Comorbidity in older adults with cancer. J Geriatr Oncol. 2016;7(4):249–57.

    Article  Google Scholar 

  16. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314(10):1021–9.

    Article  CAS  Google Scholar 

  17. Kannel WB, Vokonas PS. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women. Ann Epidemiol. 1992;2(1–2):5–14.

    Article  CAS  Google Scholar 

  18. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, TURDEP-II Study Group, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–80.

    Article  Google Scholar 

  19. Lee MH, Seo HJ, Shin EJ, Won YK, Jung YM, Suh SH, et al. The age-related characteristics of adults with asthma who visited emergency departments in Korea from 2007 to 2012. Allergy Asthma Proc. 2018;39(2):136–42.

    Article  Google Scholar 

  20. Jonsson H, Olafsdottir S, Sigurdardottir S, Aspelund T, Eiriksdottir G, Sigurdsson S, et al. Incidence and prevalence of total joint replacements due to osteoarthritis in the elderly: risk factors and factors associated with late life prevalence in the AGES-Reykjavik Study. BMC Musculoskelet Disord. 2016;17:14.

    Article  Google Scholar 

  21. Kaminsky DA, Chapman DG, Holbrook JT, Henderson RJ, Sugar EA, Mastronarde J, et al. Older age and obesity are associated with increased airway closure in response to methacholine in patients with asthma. Respirology. 2019;24(7):638–45.

    Article  Google Scholar 

  22. Rao AV, Demark-Wahnefried W. The older cancer survivor. Crit Rev Oncol Hematol. 2006;60:131–43.

    Article  Google Scholar 

  23. Hinz A, Krauss O, Hauss JP, Höckel M, Kortmann RD, Stolzenburg JU, et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl). 2010;19(4):522–9.

    Article  CAS  Google Scholar 

  24. Hinz A, Herzberg PY, Lordick F, Weis J, Faller H, Brähler E, et al. Age and gender differences in anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl). 2019;28(5):e13129.

    Article  Google Scholar 

  25. Hagen KB, Aas T, Kvaløy JT, Søiland H, Lind R. Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study. Breast. 2019;44:52–8.

    Article  Google Scholar 

  26. Temrel T, Şahin S. Polypharmacy and potentially inappropriate medicatıon use in gerıatrıc patients presenting to the emergency department. Turkish J Geriatr. 2019;22(1):25–31.

    Article  Google Scholar 

  27. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.

    Article  CAS  Google Scholar 

  28. Lai X, Zhu H, Huo X, Li Z. Polypharmacy in the oldest old (≥80 years of age) patients in China: a cross-sectional study. BMC Geriatr. 2018;18(1):64.

    Article  Google Scholar 

  29. Öztürk GZ, Ardıç C, Toprak D. Frequency of Polypharmacy and Use of Potentially Inappropriate Medications in the Elderly. Turkish J Geriatr. 2017;20(4):296–305.

    Google Scholar 

  30. Jorgensen TL, Herrstedt J, Friis S, Hallas J. Polypharmacy and drug use in elderly Danish cancer patients during 1996 to 2006. J Geriatr Oncol. 2012;3:33–40.

    Article  Google Scholar 

  31. Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. Am Med Dir Assoc. 2015;16(6):535.e1–12.

    Article  Google Scholar 

  32. Khaledi AR, Kazemi M, Tahmasebi M. Frequency of polypharmacy in advanced cancer patients consulted with the palliative service of Imam Khomeini Hospital (Tehran), Iran, 2017. Asian Pac J Cancer Prev. 2019;20(1):131–4.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the staff at Kayseri City Hospital (Kayseri, Turkey) who cooperated in this study.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Kayseri City Hospital, Kayseri, Turkey

    Ulaş Serkan Topaloğlu

  2. Department of Medical Oncology, Acıbadem Kayseri Hospital, Kayseri, Turkey

    Ersin Özaslan

Authors
  1. Ulaş Serkan Topaloğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ersin Özaslan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulaş Serkan Topaloğlu.

Ethics declarations

Conflict of interest

All authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Ersin Özaslan: During the writing phase of the study, Ersin Özaslan was assigned to Acıbadem Kayseri Hospital.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Topaloğlu, U.S., Özaslan, E. Comorbidity and polypharmacy in patients with breast cancer. Breast Cancer 27, 477–482 (2020). https://doi.org/10.1007/s12282-019-01040-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-019-01040-8

Keywords

Search

Navigation